Paul Devroey

Q: What Schools Are Affiliated With Paul Devroey

Paul Devroey is affiliated with the following schools: Vrije Universiteit Brussel

Paul Devroey's AcademicInfluence.com Rankings

Paul Devroey

Philosophy

#3556

World Rank

#5720

Historical Rank

Logic

#1238

World Rank

#1933

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Paul Devroey's Degrees

PhD Medicine Vrije Universiteit Brussel
Doctorate Medicine Vrije Universiteit Brussel

Why Is Paul Devroey Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Paul Devroey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pregnancies after intracytoplasmic injection of single spermatozoon into an oocyte (1992) (3259)
High fertilization and implantation rates after intracytoplasmic sperm injection (1993) (928)
Clinical implications of uterine malformations and hysteroscopic treatment results. (2001) (846)
Fertility and ageing. (2005) (565)
Infertility and the provision of infertility medical services in developing countries (2008) (550)
Pregnancies after testicular sperm extraction and intracytoplasmic sperm injection in non-obstructive azoospermia. (1995) (549)
Cytogenetics of infertile men. (1996) (521)
Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. (2004) (514)
Neonatal data on a cohort of 2889 infants born after ICSI (1991-1999) and of 2995 infants born after IVF (1983-1999). (2002) (512)
Higher success rate by intracytoplasmic sperm injection than by subzonal insemination. Report of a second series of 300 consecutive treatment cycles. (1993) (493)
The result of intracytoplasmic sperm injection is not related to any of the three basic sperm parameters. (1995) (472)
High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy. (1995) (462)
Consensus on infertility treatment related to polycystic ovary syndrome (2008) (448)
Prenatal testing in ICSI pregnancies: incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm parameters. (2002) (417)
An OHSS-Free Clinic by segmentation of IVF treatment. (2011) (409)
Are there any predictive factors for successful testicular sperm recovery in azoospermic patients? (1997) (399)
Multiple birth resulting from ovarian stimulation for subfertility treatment (2005) (387)
In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos. (2006) (363)
Sperm characteristics and outcome of human assisted fertilization by subzonal insemination and intracytoplasmic sperm injection (1993) (339)
Primary ovarian insufficiency (2010) (336)
Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. (2002) (332)
Microsurgical epididymal sperm aspiration and intracytoplasmic sperm injection: a new effective approach to infertility as a result of congenital bilateral absence of the vas deferens. (1994) (330)
Conventional in-vitro fertilization versus intracytoplasmic sperm injection for patients requiring microsurgical sperm aspiration. (1994) (327)
The endometrium in stimulated cycles for IVF. (2003) (309)
Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group. (2000) (302)
Using ejaculated, fresh, and frozen-thawed epididymal and testicular spermatozoa gives rise to comparable results after intracytoplasmic sperm injection. (1995) (296)
Normal fertilization of human oocytes after testicular sperm extraction and intracytoplasmic sperm injection. (1994) (291)
High fertilization and implantation rates after intracytoplasmic sperm injection. (1994) (290)
Incidence and prediction of ovarian hyperstimulation syndrome in women undergoing gonadotropin-releasing hormone antagonist in vitro fertilization cycles. (2006) (288)
Clinical outcome following stimulation with highly purified hMG or recombinant FSH in patients undergoing IVF: a randomized assessor-blind controlled trial. (2006) (285)
Correlation between testicular histology and outcome after intracytoplasmic sperm injection using testicular spermatozoa. (1996) (281)
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. (2005) (273)
A review of ten years experience of ICSI. (2004) (259)
The role of the endometrium and embryo in human implantation. (2007) (253)
Derivation of human embryonic stem cell lines from embryos obtained after IVF and after PGD for monogenic disorders. (2006) (244)
Influence of individual sperm morphology on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic sperm injection. (2003) (239)
Seven years of intracytoplasmic sperm injection and follow-up of 1987 subsequent children. (1999) (238)
Distribution of spermatogenesis in the testicles of azoospermic men: the presence or absence of spermatids in the testes of men with germinal failure. (1997) (235)
The luteal phase and early pregnancy after combined GnRH-agonist/HMG treatment for superovulation in IVF or GIFT. (1988) (235)
Reproductive biology and IVF: ovarian stimulation and endometrial receptivity (2004) (235)
Reproductive biology and IVF: ovarian stimulation and luteal phase consequences (2003) (231)
The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. (1995) (231)
GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis. (2006) (227)
Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. (1997) (226)
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks. (1999) (225)
Thyroid dysfunction and autoimmunity in infertile women. (2002) (222)
Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. (2006) (221)
Endometrial evaluation by aspiration biopsy on the day of oocyte retrieval in the embryo transfer cycles in patients with serum progesterone rise during the follicular phase. (1997) (219)
Which is the best sperm retrieval technique for non-obstructive azoospermia? A systematic review. (2007) (218)
Is progesterone elevation on the day of human chorionic gonadotrophin administration associated with the probability of pregnancy in in vitro fertilization? A systematic review and meta-analysis. (2007) (216)
Normal pregnancies resulting from testicular sperm extraction and intracytoplasmic sperm injection for azoospermia due to maturation arrest. (1996) (208)
Testicular sperm recovery in nine 47,XXY Klinefelter patients. (1996) (208)
GnRH antagonists in ovarian stimulation for IVF. (2006) (206)
Incidence of chromosomal aberrations in children born after assisted reproduction through intracytoplasmic sperm injection. (1998) (203)
Prospective follow-up study of 877 children born after intracytoplasmic sperm injection (ICSI), with ejaculated epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. (1996) (195)
A double-blind, non-inferiority RCT comparing corifollitropin alfa and recombinant FSH during the first seven days of ovarian stimulation using a GnRH antagonist protocol (2009) (195)
Follow-up of children born after ICSI. (2002) (195)
The relationship between embryo quality and the occurrence of multiple pregnancies (1992) (195)
Live birth rate is significantly higher after blastocyst transfer than after cleavage-stage embryo transfer when at least four embryos are available on day 3 of embryo culture. A randomized prospective study. (2005) (194)
Mild ovarian stimulation for IVF. (2008) (194)
Diagnostic efficiency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis. (2008) (193)
Prevalence of unsuspected uterine cavity abnormalities diagnosed by office hysteroscopy prior to in vitro fertilization. (2010) (192)
Oocyte cryopreservation for age-related fertility loss. (2012) (191)
Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation. (2008) (188)
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis (2008) (188)
A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? (2011) (185)
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients. (2006) (175)
An update of luteal phase support in stimulated IVF cycles. (2007) (174)
Time-course of oocyte activation, pronucleus formation and cleavage in human oocytes fertilized by intracytoplasmic sperm injection. (1994) (173)
Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy. (2003) (173)
Neonatal outcome of 937 children born after transfer of cryopreserved embryos obtained by ICSI and IVF and comparison with outcome data of fresh ICSI and IVF cycles. (2008) (171)
Avoidance of triplet pregnancies by elective transfer of two good quality embryos. (1993) (171)
Intracytoplasmic sperm injection. (1994) (168)
Progesterone rise on HCG day in GnRH antagonist/rFSH stimulated cycles affects endometrial gene expression. (2011) (166)
Forty years of IVF. (2018) (165)
Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. (2000) (164)
Management of failed cycles in an IVF/GIFT programme with the combination of a GnRH analogue and HMG. (1987) (164)
Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. (2008) (162)
Recent concepts in the management of infertility because of non-obstructive azoospermia. (1995) (159)
ESHRE task force on ethics and law 15: cross-border reproductive care. (2008) (158)
Severe ovarian hyperstimulation syndrome after gonadotropin-releasing hormone (GnRH) agonist trigger and "freeze-all" approach in GnRH antagonist protocol. (2014) (158)
Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. (2003) (157)
Social determinants of human reproduction. (2001) (154)
Effects of natural progesterone on the morphology of the endometrium in patients with primary ovarian failure. (1990) (154)
PGD in 47,XXY Klinefelter's syndrome patients. (2003) (153)
Blastocyst formation in in vitro fertilization versus intracytoplasmic sperm injection cycles: influence of the fertilization procedure. (2005) (152)
Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. (2004) (150)
Prospective follow-up study of 423 children born after intracytoplasmic sperm injection. (1996) (149)
A prospective randomized comparison of intramuscular or intravaginal natural progesterone as a luteal phase and early pregnancy supplement. (1992) (149)
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. (2004) (147)
The influence of the site of sperm deposition and mode of oolemma breakage at intracytoplasmic sperm injection on fertilization and embryo development rates. (1995) (145)
The impact of chronic endometritis on reproductive outcome. (2011) (141)
Impact of cleavage-stage embryo biopsy in view of PGD on human blastocyst implantation: a prospective cohort of single embryo transfers. (2009) (139)
A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age. (2011) (138)
Comparative follow-up study of 130 children born after intracytoplasmic sperm injection and 130 children born after in-vitro fertilization. (1995) (138)
Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. (2009) (138)
Assisted reproduction and thyroid autoimmunity: an unfortunate combination? (2003) (137)
Early and late ovarian hyperstimulation syndrome: early pregnancy outcome and profile. (2005) (136)
Pregnancy and birth after intracytoplasmic sperm injection of in vitro matured germinal-vesicle stage oocytes: case report. (1996) (135)
Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. (1996) (134)
Hysteroscopic septum resection in patients with recurrent abortions or infertility. (1998) (133)
Developmental outcome at 2 years of age for children born after ICSI compared with children born after IVF. (2003) (133)
Advances in recombinant DNA technology: corifollitropin alfa, a hybrid molecule with sustained follicle-stimulating activity and reduced injection frequency. (2009) (133)
Cumulus cell gene expression is associated with oocyte developmental quality and influenced by patient and treatment characteristics. (2010) (132)
No differences in outcome after intracytoplasmic sperm injection with fresh or with frozen-thawed epididymal spermatozoa. (1999) (131)
Results of 55 intracytoplasmic sperm injection cycles in the treatment of male-immunological infertility. (1995) (129)
Steroid receptor expression in late follicular phase endometrium in GnRH antagonist IVF cycles is already altered, indicating initiation of early luteal phase transformation in the absence of secretory changes. (2005) (129)
Sex chromosome abnormalities after intracytoplasmic sperm injection (1995) (127)
Report on a consecutive series of 581 children born after blastomere biopsy for preimplantation genetic diagnosis. (2010) (127)
Ongoing pregnancies and birth after intracytoplasmic sperm injection with frozen-thawed epididymal spermatozoa. (1995) (127)
Can biological or clinical parameters predict testicular sperm recovery in 47,XXY Klinefelter's syndrome patients? (2004) (125)
Successful fertilization and establishment of pregnancies after intracytoplasmic sperm injection in patients with globozoospermia. (1995) (125)
The evolution and outcome of pregnancies from oocyte donation. (1994) (124)
Intracytoplasmic sperm injection with testicular spermatozoa is less successful in men with nonobstructive azoospermia than in men with obstructive azoospermia. (2003) (123)
Results from the International Consensus Conference on Myo-inositol and d-chiro-inositol in Obstetrics and Gynecology: the link between metabolic syndrome and PCOS. (2015) (123)
ESHRE Task Force on Ethics and Law 23: medically assisted reproduction in singles, lesbian and gay couples, and transsexual people†. (2014) (122)
Serum inhibin B cannot predict testicular sperm retrieval in patients with non-obstructive azoospermia. (2002) (122)
Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle. (2010) (120)
Comparison of four mechanical methods to retrieve spermatozoa from testicular tissue. (1995) (119)
The influence of body weight on response to ovulation induction with gonadotrophins in 335 women with World Health Organization group II anovulatory infertility (2006) (118)
Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. (2008) (118)
Intracytoplasmic single sperm injection of 1-day-old unfertilized human oocytes. (1993) (118)
Cumulus cell gene expression predicts better cleavage-stage embryo or blastocyst development and pregnancy for ICSI patients. (2011) (117)
Sertoli cell only revisited. (1995) (116)
Counselling couples and donors for oocyte donation: the decision to use either known or anonymous oocytes. (2000) (116)
Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. (1990) (115)
Improving the patient's experience of IVF/ICSI: a proposal for an ovarian stimulation protocol with GnRH antagonist co-treatment. (2008) (115)
Taskforce 5: preimplantation genetic diagnosis. (2003) (114)
Elevated progesterone during ovarian stimulation for IVF. (2012) (114)
Preimplantation diagnosis for X and Y normality in embryos from three Klinefelter patients. (1996) (113)
The effect of female age and ovarian reserve on pregnancy rate in male infertility: treatment of azoospermia with sperm retrieval and intracytoplasmic sperm injection. (1997) (112)
PREGNANCY AFTER TRANSLAPAROSCOPIC ZYGOTE INTRAFALLOPIAN TRANSFER IN A PATIENT WITH SPERM ANTIBODIES (1986) (112)
Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol. (1992) (111)
Impact of ovarian stimulation on corpus luteum function and embryonic implantation. (2002) (110)
Health and fertility in World Health Organization group 2 anovulatory women. (2012) (110)
Elective single embryo transfer (2008) (110)
The relationship of premature progesterone rise with serum estradiol levels and number of follicles in GnRH antagonist/recombinant FSH-stimulated cycles. (2012) (110)
Results of intracytoplasmic sperm injection with ejaculated, fresh and frozen-thawed epididymal and testicular spermatozoa. (1998) (109)
The luteal phase of nonsupplemented cycles after ovarian superovulation with human menopausal gonadotropin and the gonadotropin-releasing hormone antagonist Cetrorelix. (1998) (108)
Live delivery rates in subfertile women with Asherman's syndrome after hysteroscopic adhesiolysis using the resectoscope or the Versapoint system. (2004) (107)
A randomized assessor-blind trial comparing highly purified hMG and recombinant FSH in a GnRH antagonist cycle with compulsory single-blastocyst transfer. (2012) (107)
Absolute asthenozoospermia and ICSI: what are the options? (2011) (107)
Contemporary genetic technologies and female reproduction (2011) (107)
Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature. (2014) (107)
Intracytoplasmic sperm injection versus in vitro fertilization: a randomized controlled trial and a meta-analysis of the literature. (2002) (106)
Lifestyle-related factors and access to medically assisted reproduction. (2010) (106)
Live birth rates after transfer of equal number of blastocysts or cleavage-stage embryos in IVF. A systematic review and meta-analysis. (2007) (105)
Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. (2012) (105)
Ovarian stimulation for assisted reproduction with HMG and concomitant midcycle administration of the GnRH antagonist cetrorelix according to the multiple dose protocol: a prospective uncontrolled phase III study. (2000) (105)
Preimplantation genetic diagnosis for aneuploidy screening in patients with unexplained recurrent miscarriages. (2005) (105)
Outcome of intracytoplasmic sperm injection with testicular spermatozoa in obstructive and non-obstructive azoospermia. (1996) (105)
Surgical sperm retrieval for intracytoplasmic sperm injection. (1997) (105)
Viability of partially damaged human embryos after cryopreservation. (1997) (104)
Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity. (2004) (104)
A prospective randomized study on oestradiol valerate supplementation in addition to intravaginal micronized progesterone in buserelin and HMG induced superovulation. (1993) (104)
Analysis of 76 total fertilization failure cycles out of 2732 intracytoplasmic sperm injection cycles. (1995) (103)
Europe the continent with the lowest fertility. (2010) (102)
Novel universal approach for preimplantation genetic diagnosis of beta-thalassaemia in combination with HLA matching of embryos. (2004) (102)
Progesterone administration in patients with absent ovaries. (1989) (102)
Performance of different embryo transfer catheters in a human in vitro fertilization program. (1989) (102)
Approaches to improve the diagnosis and management of infertility (2009) (102)
Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF. (2004) (101)
Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. (2016) (101)
Induction of acrosome reaction in human spermatozoa used for subzonal insemination. (1992) (101)
A follow-up study of children born after intracytoplasmic sperm injection (ICSI) with epididymal and testicular spermatozoa and after replacement of cryopreserved embryos obtained after ICSI. (1998) (98)
Selective transfer of cryopreserved human embryos with further cleavage after thawing increases delivery and implantation rates. (1997) (97)
Does the estradiol level on the day of human chorionic gonadotrophin administration have an impact on pregnancy rates in patients treated with rec-FSH/GnRH antagonist? (2009) (97)
Human Oocytes Reversibly Arrested in Prophase I by Phosphodiesterase Type 3 Inhibitor In Vitro1 (2003) (96)
ESHRE Task Force on Ethics and Law 13: the welfare of the child in medically assisted reproduction. (2007) (96)
Association of estradiol levels on the day of hCG administration and pregnancy achievement in IVF: a systematic review. (2004) (95)
A novel method of luteal supplementation with recombinant luteinizing hormone when a gonadotropin-releasing hormone agonist is used instead of human chorionic gonadotropin for ovulation triggering: a randomized prospective proof of concept study. (2011) (94)
Cross-border reproductive care in Belgium. (2009) (94)
Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. (2003) (94)
ESHRE Task Force on Ethics and Law 10: surrogacy. (2005) (94)
Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization. (2004) (93)
Fertility after hysteroscopic myomectomy. (1995) (92)
One year's experience with elective transfer of two good quality embryos in the human in-vitro fertilization and intracytoplasmic sperm injection programmes. (1995) (92)
Comparison of LH concentrations in the early and mid-luteal phase in IVF cycles after treatment with HMG alone or in association with the GnRH antagonist Cetrorelix. (2001) (92)
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide®) in controlled ovarian stimulation for assisted reproduction (2000) (91)
Neonatal outcome of 724 children born after ICSI using non-ejaculated sperm. (2011) (91)
Successful preimplantation genetic diagnosis is related to the number of available cumulus-oocyte complexes. (1998) (91)
In GnRH antagonist/rec-FSH stimulated cycles, advanced endometrial maturation on the day of oocyte retrieval correlates with altered gene expression. (2009) (91)
Birth after preimplantation diagnosis of the cystic fibrosis delta F508 mutation by polymerase chain reaction in human embryos resulting from intracytoplasmic sperm injection with epididymal sperm. (1994) (89)
Obstetric outcome of 424 pregnancies after intracytoplasmic sperm injection. (1995) (89)
Human embryonic stem cell lines derived from single blastomeres of two 4-cell stage embryos (2009) (88)
Obstetric outcome in donor oocyte pregnancies: a matched-pair analysis (2012) (87)
The four blastomeres of a 4-cell stage human embryo are able to develop individually into blastocysts with inner cell mass and trophectoderm. (2008) (87)
Comparison of the results of human embryo biopsy and outcome of PGD after zona drilling using acid Tyrode medium or a laser. (2003) (87)
Obstetric outcome of pregnancies after the transfer of cryopreserved and fresh embryos obtained by conventional in-vitro fertilization and intracytoplasmic sperm injection. (1999) (87)
Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. (2005) (87)
Oocyte and embryo quality as well as pregnancy rate in intracytoplasmic sperm injection are not affected by high follicular phase serum progesterone. (1995) (87)
Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial. (2006) (86)
Transvaginal removal of gallbladders with large stones after laparoscopic cholecystectomy. (1993) (86)
Cytogenetic and morphological observations of single pronucleated human oocytes after in-vitro fertilization. (1993) (86)
Outcome of closed blastocyst vitrification in relation to blastocyst quality: evaluation of 759 warming cycles in a single-embryo transfer policy. (2011) (85)
Cryopreservation of supernumerary multicellular human embryos obtained after intracytoplasmic sperm injection. (1994) (85)
Triggering of final oocyte maturation with gonadotropin-releasing hormone agonist or human chorionic gonadotropin. Live birth after frozen-thawed embryo replacement cycles. (2007) (85)
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cycles. (1999) (85)
Misoprostol prior to hysteroscopy in premenopausal and post-menopausal women. A systematic review and meta-analysis. (2012) (82)
Female age predicts embryonic implantation after ICSI: a case-controlled study. (1996) (82)
Should diagnostic testicular sperm retrieval followed by cryopreservation for later ICSI be the procedure of choice for all patients with non-obstructive azoospermia? (2004) (82)
New Belgian embryo transfer policy leads to sharp decrease in multiple pregnancy rate. (2006) (82)
Prospective follow-up study of 55 children born after subzonal insemination and intracytoplasmic sperm injection. (1994) (82)
Cystic fibrosis and infertility caused by congenital bilateral absence of the vas deferens and related clinical entities. (1996) (82)
The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives. (2012) (81)
An improved treatment procedure for testicular biopsy specimens offers more efficient sperm recovery: case series. (1997) (81)
Study of two markers of apoptosis and meiotic segregation in ejaculated sperm of chromosomal translocation carrier patients. (2006) (81)
Cumulative delivery rates after intracytoplasmic sperm injection: 5 year follow-up of 498 patients. (1999) (80)
Endometrial thickness cannot predict ongoing pregnancy achievement in cycles stimulated with clomiphene citrate for intrauterine insemination. (2004) (80)
Are ICSI adolescents at risk for increased adiposity? (2012) (80)
Endocrinology: Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist Cetrorelix in intracytoplasmic sperm injection cycles (1996) (79)
Perinatal outcome of pregnancy after GnRH antagonist (ganirelix) treatment during ovarian stimulation for conventional IVF or ICSI: a preliminary report. (2001) (79)
Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow? (2005) (78)
Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study. (2003) (78)
The use of testicular sperm for intracytoplasmic sperm injection in patients with necrozoospermia. (1996) (77)
Human chorionic gonadotropin administration vs. luteinizing monitoring for intrauterine insemination timing, after administration of clomiphene citrate: a meta-analysis. (2007) (77)
How successful is repeat testicular sperm extraction in patients with azoospermia? (2006) (76)
Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimens. (1994) (76)
Getting pregnant after tubal sterilization: surgical reversal or IVF? (2007) (75)
Human trophectoderm cells are not yet committed. (2013) (75)
Modified natural cycle for IVF does not offer a realistic chance of parenthood in poor responders with high day 3 FSH levels, as a last resort prior to oocyte donation. (2004) (75)
Endometrial hormone receptors and proliferation index in the periovulatory phase of stimulated embryo transfer cycles in comparison with natural cycles and relation to clinical pregnancy outcome. (2002) (75)
Current value of preimplantation genetic aneuploidy screening in IVF. (2007) (75)
Reproductive potential of a metaphase II oocyte retrieved after ovarian stimulation: an analysis of 23 354 ICSI cycles. (2012) (74)
Children from anonymous donors: an inquiry into homosexual and heterosexual parents' attitudes. (1993) (74)
Clinical outcome of non-hCG-primed oocyte in vitro maturation treatment in patients with polycystic ovaries and polycystic ovary syndrome. (2011) (74)
Fine needle aspiration versus open biopsy for testicular sperm recovery: a controlled study in azoospermic patients with normal spermatogenesis. (1998) (73)
Correlation between motility of testicular spermatozoa, testicular histology and the outcome of intracytoplasmic sperm injection. (1998) (72)
Hormonal profile during the follicular phase in cycles stimulated with a combination of human menopausal gonadotrophin and gonadotrophin-releasing hormone antagonist (Cetrorelix). (1996) (72)
Monozygotic twinning is not increased after single blastocyst transfer compared with single cleavage-stage embryo transfer. (2010) (72)
ESHRE Task Force on Ethics and Law 14: equity of access to assisted reproductive technology. (2008) (72)
Nafarelin for endometriosis: A large‐scale, danazol‐controlled trial of efficacy and safety, with 1‐year follow‐up (1992) (71)
Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. (2005) (70)
Human endometrial maturation is markedly improved after luteal supplementation of gonadotrophin-releasing hormone analogue/human menopausal gonadotrophin stimulated cycles. (1994) (70)
The luteal phase after ovarian stimulation. (2002) (70)
The luteal phase after in-vitro fertilization and related procedures. (1988) (70)
The reliability of the histological diagnosis of endometritis in asymptomatic IVF cases: a multicenter observer study. (2012) (70)
Clinical and biological characterization of macroprolactinemia with and without prolactin-IgG complexes. (2003) (69)
Clinical application of preimplantation diagnosis for myotonic dystrophy (1997) (69)
Taskforce 7: Ethical considerations for the cryopreservation of gametes and reproductive tissues for self use. (2004) (69)
HLA-G Expression in Human Embryonic Stem Cells and Preimplantation Embryos (2011) (68)
Developmental stage on day-5 and fragmentation rate on day-3 can influence the implantation potential of top-quality blastocysts in IVF cycles with single embryo transfer (2007) (68)
Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology – assisted reproduction technology (2015) (68)
ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. (2006) (68)
Preimplantation genetic diagnosis for Huntington's disease with exclusion testing (2002) (68)
Oocyte and embryo donation: evaluation of 412 consecutive trials. (1992) (67)
Genetic aspects of female reproduction. (2008) (67)
Use of cetrorelix in combination with clomiphene citrate and gonadotrophins: a suitable approach to 'friendly IVF'? (2002) (67)
Andrology: Intracytoplasmic sperm injection does not require special treatment pf the spermatozoa (1994) (66)
Recovery of microorganisms in semen and relationship to semen evaluation. (1986) (66)
New candidate genes to predict pregnancy outcome in single embryo transfer cycles when using cumulus cell gene expression. (2012) (66)
Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. (2004) (66)
The Brussels' experience of more than 5 years of clinical preimplantation genetic diagnosis. (2000) (65)
Clinical validation of a closed vitrification system in an oocyte-donation programme. (2012) (65)
Obstetric outcome of 904 pregnancies after intracytoplasmic sperm injection. (1996) (65)
Fertilizing capacity of epididymal and testicular sperm using intracytoplasmic sperm injection (ICSI). (1995) (64)
Assisted reproductive technologies are an integrated part of national strategies addressing demographic and reproductive challenges. (2008) (64)
Addition of Buserelin to human menopausal gonadotrophins in patients with failed stimulations for IVF or GIFT. (1988) (64)
Successful treatment of an aggressive recurrent post-menopausal endometriosis with an aromatase inhibitor. (2005) (64)
6. Ethical issues related to multiple pregnancies in medically assisted procreation. (2003) (63)
Pregnancy outcome and neonatal data of children born after ICSI using testicular sperm in obstructive and non-obstructive azoospermia. (2002) (63)
Ovulation Induction Disrupts Luteal Phase Function (2001) (62)
Chromosomal aneuploidy in embryos conceived with unstimulated cycle IVF. (2008) (62)
Clinical experience with preimplantation genetic diagnosis and intracytoplasmic sperm injection. (1998) (62)
Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. (2006) (62)
Intracytoplasmic sperm injection (ICSI) in 2006: evidence and evolution. (2007) (62)
Preimplantation genetic diagnosis for fragile Xa syndrome: difficult but not impossible. (2002) (61)
Initiation of gonadotropin-releasing hormone antagonist on day 1 as compared to day 6 of stimulation: effect on hormonal levels and follicular development in in vitro fertilization cycles. (2003) (61)
Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study. (2006) (61)
Progesterone for the luteal support of assisted reproductive technologies: clinical options. (2000) (61)
Primary Ovarian Failure (1988) (60)
The predictive value of uterine artery blood flow measurements for uterine receptivity in an intracytoplasmic sperm injection program. (1997) (60)
Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH (1992) (59)
A randomized dose-response trial of a single injection of corifollitropin alfa to sustain multifollicular growth during controlled ovarian stimulation. (2008) (59)
Exogenous luteinizing hormone activity may influence the treatment outcome in in vitro fertilization but not in intracytoplasmic sperm injection cycles. (2004) (59)
Should we advise patients undergoing IVF to start a cycle leading to a day 3 or a day 5 transfer? (2004) (58)
Economic aspects of infertility care: a challenge for researchers and clinicians. (2015) (57)
Prediction of Ovarian Hyperstimulation Syndrome in Patients Treated with Corifollitropin alfa or rFSH in a GnRH Antagonist Protocol (2016) (57)
Addition of estradiol to progesterone for luteal supplementation in patients stimulated with GnRH antagonist/rFSH for IVF: a randomized controlled trial. (2006) (57)
Is the use of donor sperm associated with a higher incidence of preeclampsia in women who achieve pregnancy after intrauterine insemination? (2010) (57)
First live birth after ovarian stimulation using a chimeric long-acting human recombinant follicle-stimulating hormone (FSH) agonist (recFSH-CTP) for in vitro fertilization. (2003) (56)
Analysis of the risk factors with regard to the occurrence of ectopic pregnancy after medically assisted procreation. (1993) (56)
Increased live birth rates with GnRH agonist addition for luteal support in ICSI/IVF cycles: a systematic review and meta-analysis. (2011) (56)
Propofol concentrations in follicular fluid during general anaesthesia for transvaginal oocyte retrieval. (1999) (56)
Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles. (1999) (56)
The experience of two European preimplantation genetic diagnosis centres on human leukocyte antigen typing. (2008) (55)
Female infertility: Treatment options for complicated cases (1997) (55)
Luteal hormonal profile of oocyte donors stimulated with a GnRH antagonist compared with natural cycles. (2006) (55)
Comparison of in-vitro fertilization in male and tubal infertility: a 3 year survey. (1992) (55)
Comparison of the aneuploidy frequency in embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men. (2004) (54)
Bilateral salpingectomy does not compromise ovarian stimulation in an in-vitro fertilization/embryo transfer programme. (1994) (54)
Chromosome studies and fertility treatment in women with ovarian failure (1989) (53)
Patients with absolutely immotile spermatozoa and intracytoplasmic sperm injection. (1997) (53)
Hyperstimulation: the need for cryopreservation of embryos. (1988) (53)
The role of transvaginal ultrasonography in the detection of pelvic pathologies in the infertility workup. (1998) (53)
Alternative approaches in IVF. (2002) (51)
ESHRE Task Force on Ethics and Law 12: oocyte donation for non-reproductive purposes. (2007) (51)
Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. (2011) (51)
Comparison between human serum and Albuminar-20 (TM) supplement for in-vitro fertilization. (1990) (51)
ESHRE Task Force on ethics and Law 20: sex selection for non-medical reasons. (2013) (51)
Preparation of endometrium for egg donation. (1998) (51)
Health of 227 children born after controlled ovarian stimulation for in vitro fertilization using the luteinizing hormone-releasing hormone antagonist cetrorelix. (2001) (50)
Do we treat the male or his gamete? (1998) (49)
Triggering final oocyte maturation using different doses of human chorionic gonadotropin: a randomized pilot study in patients with polycystic ovary syndrome treated with gonadotropin-releasing hormone antagonists and recombinant follicle-stimulating hormone. (2007) (49)
Comparison of hCG triggering versus hCG in combination with a GnRH agonist: a prospective randomized controlled trial (2014) (49)
Small diameter laparoscopy using a microlaparoscope. (1995) (49)
Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study. (2009) (49)
Taskforce 8: ethics of medically assisted fertility treatment for HIV positive men and women. (2004) (49)
Pubertal development in ICSI children. (2012) (49)
Blood pressure in ICSI-conceived adolescents. (2012) (49)
Effect of clomiphene citrate on follicular and luteal phase luteinizing hormone concentrations in in vitro fertilization cycles stimulated with gonadotropins and gonadotropin-releasing hormone antagonist. (2002) (48)
An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. (2003) (48)
Prospective, auto-controlled study on reinsemination of failed-fertilized oocytes by intracytoplasmic sperm injection. (1995) (48)
Developmental capacity of in vitro-matured human oocytes retrieved from polycystic ovary syndrome ovaries containing no follicles larger than 6 mm. (2012) (48)
Preimplantation genetic diagnosis for neurofibromatosis type 1. (2005) (47)
Pharmacodynamics of a single low dose of long-acting recombinant follicle-stimulating hormone (FSH-carboxy terminal peptide, corifollitropin alfa) in women with World Health Organization group II anovulatory infertility. (2004) (47)
Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. (1996) (47)
ESHRE task force on ethics and Law22: preimplantation genetic diagnosis. (2014) (47)
Antibiotic prophylaxis for hysteroscopy evaluation of the uterine cavity. (2011) (47)
Obstetric outcome after prenatal diagnosis in pregnancies obtained after intracytoplasmic sperm injection. (1998) (47)
Laparoscopic removal of benign mature teratoma. (1992) (47)
Use of assisted fertilization. (1993) (47)
Hormonal monitoring for in-vitro fertilization and related procedures. (1988) (46)
ESHRE Task Force on Ethics and Law 21: genetic screening of gamete donors: ethical issues. (2014) (46)
The development of intracytoplasmic sperm injection. (1996) (46)
Comparison of assisted reproductive technology performance after oocyte retrieval under general anaesthesia (propofol) versus paracervical local anaesthetic block: a case-controlled study. (1998) (46)
The use of a 100 IU starting dose of recombinant follicle stimulating hormone (Puregon) in in-vitro fertilization. (1998) (46)
Lesbian mothers who conceived after donor insemination: a follow-up study. (1995) (46)
Cumulative delivery rates in different age groups after artificial insemination with donor sperm. (2009) (46)
Closed blastocyst vitrification of biopsied embryos: evaluation of 100 consecutive warming cycles. (2011) (45)
Outcome of testicular sperm recovery and ICSI in patients with non-obstructive azoospermia with a history of orchidopexy. (2004) (45)
Effect of human chorionic gonadotropin on luteal luteinizing hormone concentrations in natural cycles. (2003) (45)
Pregnancy and birth in an in-vitro fertilization cycle after controlled ovarian stimulation in a woman with a history of allergic reaction to human menopausal gonadotrophin. (1996) (45)
Luteal phase support in normo-ovulatory women stimulated with clomiphene citrate for intrauterine insemination: need or habit? (2010) (44)
Corifollitropin alfa followed by rFSH in a GnRH antagonist protocol for poor ovarian responder patients: an observational pilot study. (2013) (44)
Cumulative delivery rates after ICSI treatment cycles with freshly retrieved testicular sperm: a 7-year follow-up study. (2003) (44)
Oocyte donation in patients without ovarian function. (1988) (44)
Vaginal progesterone supplementation has no effect on ongoing pregnancy rate in hCG-induced natural frozen-thawed embryo transfer cycles. (2010) (44)
Communications-in-briefIn vitro fertilization techniques with frozen-thawed sperm: a method for preserving the progenitive potential of Hodgkin patients* (1991) (44)
Human embryo viability after freezing with dimethylsulfoxide as a cryoprotectant. (1989) (44)
Chromosome aberrations in 500 couples referred for in-vitro fertilization or related fertility treatment. (1988) (43)
Providing infertility treatment in resource-poor countries. (2009) (43)
Early pregnancy loss is significantly higher after day 3 single embryo transfer than after day 5 single blastocyst transfer in GnRH antagonist stimulated IVF cycles. (2006) (43)
Effects and clinical significance of GnRH antagonist administration for IUI timing in FSH superovulated cycles: a meta-analysis. (2008) (42)
Slow controlled-rate freezing of sequentially cultured human blastocysts: an evaluation of two freezing strategies. (2005) (42)
Blastocyst culture: facts and fictions (2002) (42)
Treatment of infertility because of oligoasthenoteratospermia by transcervical intrauterine insemination of motile spermatozoa. (1986) (42)
Human antral follicles <6 mm: a comparison between in vivo maturation and in vitro maturation in non-hCG primed cycles using cumulus cell gene expression. (2013) (42)
Embryo reduction in triplet pregnancies after assisted procreation: a comparative study. (1993) (42)
Aromatase inhibitors in post-menopausal endometriosis (2011) (41)
Corifollitropin alfa doses based on body weight: clinical overview of drug exposure and ovarian response. (2011) (41)
Time of insemination and its effect on in-vitro fertilization, cleavage and pregnancy rates in GnRH agonist/HMG-stimulated cycles. (1989) (41)
Amplification of X- and Y-chromosome-specific regions from single human blastomeres by polymerase chain reaction for sexing of preimplantation embryos. (1994) (41)
Slightly lower incidence of ectopic pregnancies in frozen embryo transfer cycles versus fresh in vitro fertilization-embryo transfer cycles: a retrospective cohort study. (2014) (41)
GnRH antagonists in IVF. (2005) (41)
Observer agreement in the evaluation of the uterine cavity by hysteroscopy prior to in vitro fertilization. (2011) (40)
Placental production of estradiol and progesterone after oocyte donation in patients with primary ovarian failure. (1990) (40)
Tubal surgery in the era of assisted reproductive technology: clinical options. (1999) (39)
Thyroid autoimmunity and female infertility. (2006) (39)
Establishment of 22 pregnancies after oocyte and embryo donation (1989) (39)
Cumulative reproductive outcome after preimplantation genetic diagnosis: a report on 1498 couples. (2009) (39)
Spontaneous pregnancies in couples who discontinued intracytoplasmic sperm injection treatment: a 5-year follow-up study. (2002) (39)
A multicenter phase IIb study of a novel combination of intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception. (2005) (39)
Improving clinical preimplantation genetic diagnosis for cystic fibrosis by duplex PCR using two polymorphic markers or one polymorphic marker in combination with the detection of the DeltaF508 mutation. (2003) (39)
Cumulative delivery rates after ICSI in women aged >37 years. (2002) (38)
Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. (2012) (38)
Prospective randomized study on the cryopreservation of human embryos with dimethylsulfoxide or 1,2-propanediol protocols. (1995) (38)
Intrafamilial medically assisted reproduction. (2011) (38)
Ex-vivo oocyte retrieval for fertility preservation. (2011) (38)
Intracytoplasmic sperm injection, results in women older than 39, according to age and the number of embryos replaced in selective or non-selective transfers. (1998) (38)
Efficiency and accuracy of polymerase-chain-reaction assay for cystic fibrosis allele ΔF508 in single cell (1992) (38)
Pregnancy Prediction in Single Embryo Transfer Cycles after ICSI Using QPCR: Validation in Oocytes from the Same Cohort (2013) (37)
Intracytoplasmic sperm injection does not require special treatment of the spermatozoa. (1994) (37)
Oestradiol valerate pretreatment in GnRH-antagonist cycles: a randomized controlled trial. (2012) (37)
Use of pentoxifylline in assisted reproductive technology. (1995) (37)
A prediction model to select PCOS patients suitable for IVM treatment based on anti-Mullerian hormone and antral follicle count. (2013) (37)
Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. (2006) (36)
Ovulation by repeated human chorionic gonadotrophin in 'empty follicle syndrome' yields a twin clinical pregnancy. (1997) (36)
Estrogen and folliculogenesis: is one necessary for the other? (2005) (36)
First trimester screening for Down's syndrome after assisted reproductive technology: non-male factor infertility is associated with elevated free beta-human chorionic gonadotropin levels at 10-14 weeks of gestation. (2008) (36)
Pentoxifylline is not useful in enhancing sperm function in cases with previous in vitro fertilization failure. (1993) (35)
Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial. (2007) (35)
Immature oocyte in-vitro maturation: clinical aspects. (2005) (35)
The incidence of multiple pregnancy after in vitro fertilization and embryo transfer, gamete, or zygote intrafallopian transfer. (1991) (35)
In vitro fertilization techniques with frozen‐thawed sperm: A method for preserving the progenitive potential of Hodgkin patients (1992) (35)
Infertility: A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon® and Metrodin® in infertile female patients undergoing in-vitro fertilization (1995) (35)
Avoidance of multiple pregnancies after ovulation induction by supernumerary preovulatory follicular reduction. (2001) (35)
The effect of gonadotrophin-releasing hormone (GnRH) agonist in the follicular phase on in-vitro fertilization outcome in normo-ovulatory women. (1992) (34)
Highly purified HMG versus recombinant FSH for ovarian stimulation in IVF cycles. (2008) (34)
Outcome of pregnancies after intracytoplasmic sperm injection and the effect of sperm origin and quality on this outcome (1998) (34)
A randomized comparison of the cryopreservation of one-cell human embryos with a slow controlled-rate cooling procedure or a rapid cooling procedure by direct plunging into liquid nitrogen. (1997) (34)
Cancer and fertility: strategies to preserve fertility. (2011) (34)
Mild ovarian stimulation with clomiphene citrate launch is a realistic option for in vitro fertilization. (2015) (34)
Failure of fertilization after intracytoplasmic sperm injection in a patient with Kartagener's syndrome and totally immotile spermatozoa: case report. (1999) (34)
High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. (2011) (33)
Which patients with recurrent implantation failure after IVF benefit from PGD for aneuploidy screening? (2006) (33)
Controlled comparison of Earle's balanced salt solution with Ménézo B2 medium for human in-vitro fertilization performance. (1994) (33)
Protect us from poor-quality medical research. (2018) (33)
Human serum albumin versus serum: a comparative study on embryo transfer medium. (1991) (33)
Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH/GnRH antagonist affect ongoing pregnancy rates? A randomized controlled trial. (2011) (33)
Pregnancy: Effect of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro (1993) (33)
Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. (2007) (33)
The luteal phase of recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in vitro fertilization cycles during supplementation with progesterone or progesterone and estradiol. (2007) (32)
Failures (with some successes) of assisted reproduction and gamete donation programs. (2013) (32)
Effect of repeated assisted reproductive technology cycles on ovarian response. (2002) (32)
Long-term evaluation of implantation of fresh and cryopreserved human embryos following ovarian stimulation with buserelin acetate-human menopausal gonadotrophin (HMG) or clomiphene citrate-HMG. (1996) (32)
Embryo donation in patients with primary ovarian failure. (1988) (32)
Seminoma discovered in two males undergoing successful testicular sperm extraction for intracytoplasmic sperm injection. (1996) (32)
Polymerase chain reaction analysis of the cystic fibrosis ΔF508 mutation in human blastomeres following oocyte injection of a single sperm from a carrier (1993) (31)
Zygote intrafallopian transfer or in vitro fertilization and embryo transfer for the treatment of male-factor infertility: a prospective randomized trial. (1992) (31)
Counselling lesbian couples: requests for donor insemination on social grounds. (2003) (31)
Effects of pentoxifylline on in-vitro development of preimplantation mouse embryos. (1993) (31)
Comparison among different ovarian stimulation regimens for assisted procreation procedures in patients with endometriosis. (1995) (31)
Subsidized in-vitro fertilization treatment and the effect on the number of egg sharers. (2006) (31)
The role of the number of replaced embryos on intracytoplasmic sperm injection outcome in women over the age of 40. (1997) (31)
Spontaneous triggering of ovulation versus HCG administration in patients undergoing IUI: a prospective randomized study. (2012) (31)
Sex chromosome abnormalities after intracytoplasmic sperm injection. (1995) (30)
Preimplantation genetic diagnosis for Charcot-Marie-Tooth disease type 1A. (2003) (30)
Ectopic pregnancy: let's cut! Strict laparoscopic approach to 194 consecutive cases and review of literature on alternatives. (1997) (30)
The influence of inadvertent intranasal buserelin administration in early pregnancy. (1991) (30)
Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI. (2003) (30)
Intracytoplasmic sperm injection three years after the birth of the first ICSI child. (1995) (30)
Gamete intra-Fallopian transfer: evaluation of 100 consecutive attempts. (1987) (29)
Relationship between serum follicle stimulating hormone in the male and standard sperm parameters, and the results of intracytoplasmic sperm injection. (1997) (29)
Ovarian stimulation: today and tomorrow. (2012) (29)
Serum inhibin B concentrations in pubertal boys conceived by ICSI: first results. (2010) (29)
Zygote intrafallopian transfer as a successful treatment for unexplained infertility. (1989) (29)
Outcome of pregnancies after intracytoplasmic sperm injection and the effect of sperm origin and quality on this outcome. (1999) (27)
RCT to evaluate the influence of adjuvant medical treatment of peritoneal endometriosis on the outcome of IVF. (2016) (27)
Children born after assisted reproductive technology. (2002) (27)
ESHRE guidelines for training, accreditation and monitoring in gynaecological endoscopy. European Society for Human Reproduction and Embryology. Committee of Special Interest Group on Reproductive Surgery. (1997) (27)
Cytogenetics of infertile men. Discussion (1996) (27)
Commentary: major defects are overestimated (1997) (27)
The incidence of monozygotic twinning following PGD is not increased. (2009) (27)
Large prospective, pregnancy and infant follow-up trial assures the health of 1000 fetuses conceived after treatment with the GnRH antagonist ganirelix during controlled ovarian stimulation. (2010) (26)
Ovarian stimulation for in vitro fertilization in patients with endometriosis (2004) (26)
The early luteal phase administration of estrogen and progesterone does not induce premature luteolysis in normo-ovulatory women. (2006) (26)
Quintuplet pregnancy following transfer of two blastocysts: Case report. (2004) (26)
Real and expected delivery rates of patients with myotonic dystrophy undergoing intracytoplasmic sperm injection and preimplantation genetic diagnosis. (2008) (26)
In vitro fertilization in couples with previous fertilization failure using sperm incubated with pentoxifylline and 2-deoxyadenosine. (1994) (26)
Histologic and Functional Aspects of the Endometrium in the Implantatory Phase (2007) (26)
HLA-matched embryos selected for siblings requiring haematopoietic stem cell transplantation: a psychological perspective. (2005) (25)
Impact of the ovarian hyperstimulation syndrome on thyroid function. (2008) (25)
Pentoxifylline in idiopathic male-factor infertility: a review of its therapeutic efficacy after oral administration. (1994) (25)
LH concentrations do not correlate with pregnancy in rFSH/GnRH antagonist cycles. (2010) (25)
Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study. (2011) (25)
Randomized sibling-oocyte study using recombinant human hyaluronidase versus bovine-derived Sigma hyaluronidase in ICSI patients. (2008) (24)
Salivary testosterone concentrations in pubertal ICSI boys compared with spontaneously conceived boys. (2011) (24)
Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5. (2011) (24)
Emerging drugs in assisted reproduction (2005) (24)
An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos (1989) (24)
Does PGD for aneuploidy screening change the selection of embryos derived from testicular sperm extraction in obstructive and non-obstructive azoospermic men? (2006) (24)
Testicular sperm extraction and intracytoplasmic sperm injection. (1998) (24)
Principal findings from a multicenter trial investigating the safety of follicular-fluid meiosis-activating sterol for in vitro maturation of human cumulus-enclosed oocytes. (2007) (24)
Ultrasound-guided embryo transfer does not offer any benefit in clinical outcome: a randomized controlled trial. (2007) (23)
Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment? (2005) (23)
Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate (2008) (23)
Effect of ovarian stimulation and oocyte retrieval on reproductive outcome in oocyte donors. (2012) (23)
Should requests for donor insemination on social grounds be expanded to transsexuals? (2003) (23)
Does the time interval between antimüllerian hormone serum sampling and initiation of ovarian stimulation affect its predictive ability in in vitro fertilization-intracytoplasmic sperm injection cycles with a gonadotropin-releasing hormone antagonist? A retrospective single-center study. (2013) (23)
Should we advise patients undergoing in vitro fertilization to start a cycle leading to a day-3 or a day-5 transfer? (2004) (23)
Clinical application of new micromanipulative technologies to treat the male. (1998) (23)
Luteal phase oestradiol suppression by letrozole: a pilot study in oocyte donors. (2008) (22)
Duration of gonadotropin-releasing hormone antagonist administration does not affect the outcome of subsequent frozen-thawed cycles. (2004) (22)
Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. (2004) (22)
Gene expression during successful implantation in a natural cycle. (2010) (22)
Assisted fertilization by subzonal insemination and intracytoplasmic sperm injection. (1994) (22)
Endocrinology in luteal phase and implantation. (1990) (22)
No association between endogenous LH and pregnancy in a GnRH antagonist protocol: part I, corifollitropin alfa. (2011) (22)
Corifollitropin alfa in a long GnRH agonist protocol: proof of concept trial. (2010) (22)
Pregnancy with a frozen-thawed embryo in a woman with primary ovarian failure. (1987) (22)
Zygote intra-fallopian transfer as an alternative treatment for male infertility. (1989) (21)
An in vivo culture system for human embryos using an encapsulation technology: a pilot study (2008) (21)
A comparison of live birth rates and cumulative ongoing pregnancy rates between Europe and North America after ovarian stimulation with corifollitropin alfa or recombinant follicle-stimulating hormone. (2012) (21)
International Federation of Fertility Societies Surveillance 2013: preface and conclusions. (2014) (21)
In-vitro fertilization, gamete- or zygote intra-fallopian transfer for the treatment of male infertility. (1991) (20)
Sex Steroid Hormones and Reproductive Disorders (2011) (20)
Bone loss in young hypoestrogenic women due to primary ovarian failure: Spinal quantitative computed tomography (1989) (20)
Recombinant follicle-stimulating hormone (follitropin beta, Puregon*) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins † (1998) (20)
First singleton term birth after ovarian superovulation with rhFSH (1992) (20)
First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489). (1993) (20)
The influence of pentoxifylline on motility and viability of spermatozoa from normozoospermic semen samples. (1994) (20)
Endocrine profiles in early pregnancies with delayed implantation. (1986) (20)
Rescue IVF and coasting with the use of a GnRH antagonist after ovulation induction. (2002) (20)
Taskforce 9: the application of preimplantation genetic diagnosis for human leukocyte antigen typing of embryos. (2005) (19)
OHSS Free Clinic (2011) (19)
Efficiency of polymerase chain reaction assay for cystic fibrosis in single human blastomeres according to the presence or absence of nuclei. (1993) (19)
Synchronization of donor's and recipient's cycles with GnRH analogues in an oocyte donation programme. (1989) (19)
In-vitro fertilization with husband and donor sperm in patients with previous fertilization failures using husband sperm. (1988) (18)
Comparison of two local anaesthetics in transvaginal ultrasound-guided oocyte retrieval. (1993) (18)
Low-dose HCG may improve pregnancy rates and lower OHSS in antagonist cycles: a meta-analysis. (2009) (18)
The impact of LH serum concentration on the clinical outcome of IVF cycles in patients receiving two regimens of clomiphene citrate/gonadotrophin/0.25 mg cetrorelix. (2003) (18)
Implantation potential and clinical impact of cryopreservation--a review. (2003) (18)
Pregnancies After Replacement of Fresh and Frozen-Thawed Embryos in a Donation Program (1987) (17)
Assisted procreation in the presence of a positive direct mixed antiglobulin reaction test. (1989) (17)
Endometrial integrin expression in the early luteal phase in natural and stimulated cycles for in vitro fertilization. (2003) (17)
Birth defects and congenital health risks in children conceived through assisted reproduction technology (ART): a meeting report (2014) (17)
The role of oxytocin antagonists in repeated implantation failure (2012) (17)
Success rate in gamete intrafallopian transfer using low and high concentrations of washed spermatozoa (1988) (17)
Hysteroscopic septum resection using the Versapoint system in subfertile women. (2003) (17)
Semen cryobanking for men with cancer. (1993) (16)
Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: a prospective cohort study. (2011) (16)
Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors. (2012) (16)
Gene expression profile in the endometrium on the day of oocyte retrieval after ovarian stimulation with low-dose hCG in the follicular phase. (2011) (16)
The reproductive outcome of female patients with myotonic dystrophy type 1 (DM1) undergoing PGD is not affected by the size of the expanded CTG repeat tract (2010) (16)
[A randomized prospective study comparing supplementation of the luteal phase and early pregnancy by natural progesterone administered by intramuscular or vaginal route]. (1992) (16)
Analysis of the bleeding pattern in assisted reproduction cycles with luteal phase supplementation using vaginal micronized progesterone. (2000) (16)
Gonadotropin-releasing hormone antagonist: how good is the new hope? (2001) (16)
Publication bias in reproductive medicine: from the European Society of Human Reproduction and Embryology annual meeting to publication. (2011) (16)
Success of in vitro fertilization and embryo transfer in relation to the causes of infertility. (1985) (16)
Outcome for donors and recipients in two egg-sharing policies. (2003) (15)
Significantly lower ectopic pregnancy rates after frozen embryo transfer: implications toward segmentation of in vitro fertilization treatment. (2012) (15)
Mouse in vitro fertilization using sperm treated with pentoxifylline and 2-deoxyadenosine. (1994) (15)
Hyperthyroidism after gonadotrophic ovarian stimulation (1988) (15)
The effect of pentoxifylline on mouse in-vitro fertilization and early embryonic development. (1994) (15)
Preimplantation genetic diagnosis for myotonic dystrophy type 1: upon request to child (2009) (15)
Fast-release orodispersible tramadol as analgesia in hysterosalpingography with a metal cannula or a balloon catheter. (2010) (15)
Blastocyst culture: facts and fiction. (2002) (15)
In vitro fertilization pregnancy in a patient with proven chronic endometritis. (2009) (15)
PGD for aneuploidy screening: an expensive hoax? (2007) (15)
I. The moral status of the pre-implantation embryo. (2001) (15)
GnRH antagonists in poor responders (2004) (15)
Higher birth rate after recombinant hCG triggering compared with urinary-derived hCG in single-blastocyst IVF antagonist cycles: a randomized controlled trial. (2010) (14)
Improving in vitro maturation of oocytes in the human taking lessons from experiences in animal species. (2001) (14)
Incubation of spermatozoa from asthenozoospermic semen samples with pentoxifylline and 2-deoxyadenosine: variability in hyperactivation and acrosome reaction rates. (1994) (14)
Transfer of cryopreserved - thawed embryos in hCG induced natural or clomiphene citrate cycles yields similar live birth rates in normo-ovulatory women (2010) (14)
Incidence, recurrence and treatment of the luteinized unruptured follicle syndrome. (1984) (14)
Comment on the debate article: embryo implantation: the Rubicon for GnRH antagonists. (2001) (14)
Endometrial advancement after triggering with recombinant or urinary HCG: a randomized controlled pilot study. (2010) (13)
An indiscriminate use of pentoxifylline does not improve in-vitro fertilization in poor fertilizers. (1994) (13)
Preimplantation aneuploidy screening: a research tool for now (2007) (13)
Intracytoplasmic sperm injection (2002) (13)
Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. (2007) (13)
Tubal transfer: a forgotten ART? Is there still an important role for tubal transfer procedures? (1996) (13)
Plasma and follicular fluid concentrations of LHRH antagonist cetrorelix (Cetrotide®) in controlled ovarian stimulation for IVF (2002) (13)
Zygote intrafallopian transfer as a successful treatment for unexplained infertility (1990) (13)
A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilization. (1995) (13)
Relationship between LH and oestradiol in IVF cycles before GnRH antagonist initiation. (2003) (12)
Limits of agreement? (2004) (12)
Adhesions (1992) (12)
7 Cryopreservation of human embryos (1992) (12)
Auto-controlled study on in-vitro fertilization performance with 'antibody-free' spermatozoa selected by immunobead adsorption from semen of patients with anti-sperm antibodies. (1994) (12)
Results of microsurgical epididymal sperm aspiration (MESA) ans testicular sperm extraction (TESE) in azoospermic men using intracytoplasmic sperm injection (ICSI). (1996) (11)
Pregnancy and birth after high serum progesterone concentrations during the follicular phase in an in-vitro fertilization cycle with gonadotrophin-releasing hormone agonist suppression. (1995) (11)
Evaluation of one-hundred open-ended vasectomies. (1986) (11)
Laparoscopic application of interceed (TC7). (1992) (11)
Achievement of pregnancy three times in the same patient during luteal GnRH agonist administration. (2005) (10)
Successful in Vitro Fertilization with Sperm Cells from a Man with Immune Infertility (1985) (10)
Primary ovarian insuffi ciency (2010) (10)
Effect of transuterine puncture during transvaginal oocyte retrieval on the results of human in-vitro fertilization. (1989) (10)
Offering excess oocyte aspiration and vitrification to patients undergoing stimulated artificial insemination cycles can reduce the multiple pregnancy risk and accumulate oocytes for later use. (2010) (10)
Should a single blastocyst transfer policy be a clinical decision or should it depend on the embryological evaluation on day 3? (2011) (10)
Artificial insemination by donor: an alternative for single women. (1995) (10)
Pneumoperitoneum induced pH changes in follicular and Douglas fluids during laparoscopic oocyte retrieval in humans. (1988) (9)
Corifollitropin alfa or rFSH treatment flexibility options for controlled ovarian stimulation: a post hoc analysis of the Engage trial (2013) (9)
Counselling and selection of homosexual couples in fertility treatment. (1989) (9)
Updates in infertility treatment. (2009) (9)
Cumulative live birth rates after transfer of cryopreserved ICSI embryos. (2004) (9)
Recurrence of the luteinized unruptured follicle (1983) (9)
Short-term use of buserelin in combination with human menopausal gonadotrophins for ovarian stimulation for in-vitro fertilization in endocrinologically normal women. (1990) (9)
The effect of pneumoperitoneum gases on fertilization, cleavage and pregnancy in human in-vitro fertilization and gamete intra-fallopian transfer. (1989) (9)
Reproductive decisions by couples undergoing artificial insemination with donor sperm for severe male infertility: implications for medical counselling. (2005) (9)
Economic evaluation of the administration of follitropin-β with a pen device (2005) (8)
GnRH antagonists. (2000) (8)
Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic diagnosis. (1996) (8)
Ovarian stimulation, including in vitro fertilisation. (1987) (8)
P-101. Correlation between ongoing pregnancy rates and the number of cumulus-oocyte complexes retrieved in agonist-HMG-stimulated ICSI cycles (1997) (8)
Successful in-vitro fertilisation and embryo transfer after treatment with recombinant human FSH. (1992) (8)
Oocyte donation for genetic indications (1992) (8)
Effect of pentoxifylline on implantation and post-implantation development of mouse embryos in vitro. (1993) (8)
Loa loa microfilariae aspirated during oocyte retrieval. (1993) (8)
No evidence for a decreased fertilizing potential after in-vitro fertilization using spermatozoa from polyzoospermic men. (1997) (7)
Intramyometrial ectopic pregnancy in an ICSI patient following uterine artery embolization. (2010) (7)
PELVIC INFLAMMATORY DISEASE DUE TO PSEUDOMONAS FLUORESCENS IN PATIENT WEARING AN INTRAUTERINE DEVICE (1981) (7)
Amplification of exon 11 of the gene for the α-chain of ß-N-acetylhexosaminidase in single human blastomeres*† (1995) (7)
Inhibition of gonadotropic and ovarian function by intranasal administration of D-Ser (TBU)6-EA10-LHRH in normo-ovulatory women and patients with polycystic ovary disease (1988) (7)
Does PGS improve pregnancy rates in young patients with single-embryo transfer (2007) (7)
Comparison of transfers to Fallopian tubes or uterus after ICSI. (2003) (7)
Cryopreservation of human embryos. (1992) (7)
No relationship between the type of pituitary suppression for IVF and chromosomal abnormality rates of blastomeres: an observational study. (2011) (7)
Indications for and results of intracytoplasmic sperm injection (ICSI). (1995) (6)
The influence of social factors on gender health. (2016) (6)
Spuriously elevated serum estradiol concentrations measured by an automated immunoassay rarely cause unnecessary cancellation of in vitro fertilization cycles. (2006) (6)
Prospective follow-up of 838 fetuses conceived after ovarian stimulation with corifollitropin alfa: comparative and overall neonatal outcome. (2012) (6)
Effects of etomidate on ovarian steroidogenesis. (1987) (6)
Low tolerance for complications. (2013) (6)
No decrease occurs in the number of COCs retrieved with repeated IVF cycles. (2004) (5)
Session 15: Safery in Art (2010) (5)
Pregnancy in a couple with a male partner born with severe bladder exstrophy. (2004) (5)
[Ovarian stimulation regimens in women with endometriosis]. (2003) (5)
Progesterone Versus Progesterone Combined With Estradiol as Luteal Support in Cycles Stimulated With GnRH Antagonist/rec-FSH for IVF: A Randomized Clinical Trial (2005) (5)
Assisted procreation in the presence of a positive direct mixed antiglobulin reaction test (1990) (5)
Consensus on infertility treatment related to polycystic ovary syndrome (Human Reproduction (2007) 23, (462)) (2008) (5)
A survey of four years of experience with intracytoplasmic sperm injection. (1995) (5)
Cyclooxygenase-2 network as predictive molecular marker for clinical pregnancy in in vitro fertilization. (2011) (5)
Gamete intra-fallopian transfer versus in vitro fertilization and embryo transfer in endometriosis. (1987) (5)
Cystic fibrosis, Duchenne muscular dystrophy and preimplantation genetic disorders (1996) (5)
Long term follow-up of children born after inadvertent administration of a GnRH-analogue in early pregnancy. (2000) (5)
O-184. Human seminal plasma stimulates IL-10 and inhibits IL-12: a modification of immune responses that will favour both spermatozoa and sexually transmitted disease (1997) (5)
Menstruation-free interval and ongoing pregnancy in IVF using GnRH antagonists. (2006) (5)
A new approach for ovarian stimulation in IVF using Corifollitropin Alfa in combination with GnRH analogues to trigger final oocyte maturation. A pilot study (2014) (5)
Prenatal genetic testing by amniocentesis appears to result in a lower risk of fetal loss than chorionic villus sampling in singleton pregnancies achieved by intracytoplasmic sperm injection. (2003) (5)
β-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos (1992) (5)
IN VITRO FERTILIZATION AND PREIMPLANTATION DIAGNOSIS (1991) (5)
Pregnancies without corpus luteum rescue. (1987) (4)
Replacing HMG/FSH by low-dose HCG to complete corifollitropin alfa stimulation reduces cost per clinical pregnancy: a randomized pragmatic trial. (2019) (4)
Is there any need for diagnostic laparoscopy in couples undergoing intracytoplasmic sperm injection for severe male-factor infertility? (2007) (4)
Microsurgical epididymal sperm aspiration with motile trophozoite cells but no spermatozoa. (1997) (4)
Fertility preservation utilizing controlled ovarian hyperstimulation and oocyte cryopreservation in a premenarcheal female with myelodysplastic syndrome. (2012) (4)
Perurethral ultrasound-guided ovum pickup (1988) (4)
Beta-N-acetylhexosaminidase activity in human oocytes and preimplantation embryos. (1992) (4)
Evaluation of radioimmunoassays using mono- and polyclonal antibodies for the quantitation of human chorionic gonadotropin in early pregnancy. (1986) (4)
Session 32: Efficacy in ART (2010) (4)
Assisted reproductive technology by intracytoplasmic sperm injection in male-factor infertility (1996) (4)
Paramedical Programme: Invited LectureIntracytoplasmic sperm injection (1994) (4)
Intracytoplasmic sperm injection (ICSI). (1994) (3)
Ovarian adhesions impair ovulation. (1985) (3)
The effect of pentoxifylline on in-vitro fertilization in the presence of anti-sperm antibodies. (1994) (3)
Economic evaluation of the administration of follitropin-beta with a pen device. (2005) (3)
Reply of the Authors: Cryopreserved-thawed human embryo transfer: spontaneous natural cycle is superior to human chorionic gonadotropin-induced natural cycle (2010) (3)
P-205 Basement membrane integrity is altered in the late secretary phase in women with endometriosis: implications for the pathogenesis of endometriosis (2011) (3)
Four years of IVF/ICSI experience in Kampala (Uganda) (2008) (3)
Follicular and endocrine profiles associated with different GnRH-antagonist regimens: a randomized controlled trial. (2012) (3)
The luteal phase (2008) (3)
A.275 Accumulation of propofol in follicular fluid during transvaginal oocyte retrieval (1996) (3)
Progesterone Rise on the Day of HCG Administration Impairs the Pregnancy Outcome in day 3 Single Embryo Transfer, While Has no Effect on Day 5 Single Blastocyst Transfer During GnRH-Antagonist Stimulated IVF Cycles (2005) (3)
O-091. Oocyte donors: helping out family and friends (1997) (3)
Follicular rupture changes the endocrine profile of peritoneal fluid. (1985) (3)
Evaluation of commercially available radioimmunoassays for the determination of luteinizing hormone in serum and urine. Application for the detection of endogenous rise of luteinizing hormone in a in vitro fertilization program. (1984) (3)
AMH for predicting poor ovarian responders in GnRH antagonist cycles. (2012) (3)
O-19. Ongoing implantation rate after blastocyst transfer with or without PGD for aneuploidy screening in women over 37 years (a randomized controlled trial) (2002) (3)
In vitro fertilization with single blastocyst-stage versus single cleavage-stage embryos (2006) (2)
Gonadotrophin treatment in patients with previously failed stimulations for in vitro fertilization (1989) (2)
Pre-treatment with oral contraceptive pill affects adversely implantation rate in IVF/ICSI cycles stimulated with rec-FSH and GnRH antagonists (2003) (2)
Do the risks of preimplantation genetic testing for aneuploidy outbalance the benefits? (2019) (2)
CASE REPORT: Pregnancy after zygote intra-Fallopian transfer using spermatozoa from a patient with Kallmann's syndrome (1992) (2)
Follicular Fluid Profile After Stimulation With Highly Purified Menotropin and Recombinant FSH in IVF Cycles (2005) (2)
Prospective randomized controlled trial in GnRH antagonist stimulated cycles comparing hcg triggering alone versus hcg triggering associated with GnRH agonist (2013) (2)
Amplification of exon 11 of the gene for the alpha-chain of beta-N-acetylhexosaminidase in single human blastomeres. (1995) (2)
FREE COMMUNICATION (1993) (2)
Ongoing Pregnancy Rate is Significantly Higher With Day 5 Embryo Transfer Than After Day 3 Embryo Transfer, When More Than Three Embryos are Available on the Third Day of Embryo Culture (2005) (2)
Providing infertility treatment in resource-poor countries † ESHRE Task Force on Ethics and Law including (2009) (2)
Genetic contribution to male infertility. Discussion (1998) (2)
PostersEndometriosis, Endometrium and Implantation (2010) (2)
Paratesticular leiomyoma in an azoospermic patient and successful testicular sperm extraction (TESE) for intracytoplasmic sperm injection (ICSI) with an ongoing pregnancy (2012) (2)
No need for luteal phase support in IVF cycles after mild stimulation: proof-of-concept study. (2017) (2)
O-39. PGD for reciprocal and Robertsonian translocations in 41 treatment cycles (2002) (2)
Rewards and risks in ICSI (1995) (2)
Preimplantation diagnosis. (1992) (2)
R-104. Cumulative delivery rates after intracytoplasmic sperm injection in women older than 37 years (1999) (2)
Are spermatid injections of any clinical value ? Testicular sperm extraction and intracytoplasmic sperm injection (2)
POSTER VIEWING SESSION - EMBRYOLOGY (2011) (2)
Laparoscopic treatment of adnexal torsion : a report of three cases and a review of the literature (1995) (2)
Pregnancy after zygote intra-fallopian transfer using spermatozoa from a patient with Kallmann's syndrome. (1992) (2)
Reply to Comments on Staessen et al. (2004) (2005) (2)
POSTER VIEWING SESSION - ENDOMETRIOSIS, ENDOMETRIUM, IMPLANTATION AND FALLOPIAN TUBE (2011) (1)
Session 14: Paramedical Nursing (2010) (1)
P-221. The influence of the social context on the meaning of sperm donation (1999) (1)
Genetic Problems and Congenital Malformations in 1987 ICSI Children (1999) (1)
"Floating denominators"--effect of verification bias on accuracy estimates for preimplantation diagnosis. (2003) (1)
Treatment of poor ovarian responders with corifollitropin alpha followed by rFSH in an antagonist protocol. an observational pilot study (2012) (1)
[Endometriosis and sterility]. (1999) (1)
Conventional IVF vs ICSI (intracytoplasmic sperm injection) for patients requiring microsurgical epididymal sperm aspiration (MESA). (1994) (1)
Endoscopic surgery in gynecologic practice (1995) (1)
Preimplantation genetic diagnosis for neurofibromatosis (2005) (1)
Endometrial estrogen and progesterone receptors in cycles treated for infertility. (1992) (1)
international differences in IVF live birth rates and cumulative ongoing pregnancy rates following ovarian stimulation with corifollitropin alfa or recombinant FSH (2011) (1)
Health Condition of 227 Children Born After Controlled Ovarian Stimulation for IVF Using the LHRH Antagonist Cetrorelix (Cetrotide (2000) (1)
Reply: ‘GnRH agonist trigger: looking for the coin under the lamp post?’ (2006) (1)
Oocyte cryopreservation for age-related fertility loss † ESHRE Task Force on Ethics and Law, including, W. (2012) (1)
SELECTED ORAL COMMUNICATION SESSION, SESSION 44: SURGERY, Tuesday 5 July 2011 15:15 - 16:30 (2011) (1)
Quels protocoles de stimulation en cas d'endométriose. (2003) (1)
Session 41: Embryo Development & Implantation (2010) (1)
Luteinizing monitoring in natural cycle for cryopreserved -thawed embryo transfer vs. human chorionic gonadotropin administration: prospective randomized trial (2008) (1)
POSTER VIEWING SESSION - REPRODUCTIVE ENDOCRINOLOGY (2011) (1)
Early pregnancy Does cessation of progesterone supplementation during early pregnancy in patients treated with recFSH / GnRH antagonist affect ongoing pregnancy rates ? A randomized controlled trial (2011) (1)
Experimental cryopreservation: A model for the freezing of human embryos and oocytes☆ (1988) (1)
SELECTED ORAL COMMUNICATION SESSION, SESSION 50: ENDOCRINOLOGY, Tuesday 5 July 2011 17:00 – 18:00 (2011) (1)
P-226. Intracytoplasmic sperm injection: the end of donor insemination? (1999) (1)
What is the optimal moment for IUI in natural cycles? Human chorionic gonadotropin or luteinizing monitoring? Preliminary results of a randomized study (2010) (1)
Cancellation of fresh embryo transfer: A future perspective (2010) (1)
PostersReproductive Endocrinology (i.e. PCOS, Menarche, Menopause etc.) (2010) (1)
Origin of low peritoneal fluid steroid concentrations in the luteinized unruptured follicle syndrome (1984) (1)
The use of recombinant FSH for ovulation induction. (1994) (1)
Late follicular phase endometrium histology and steroid receptor expression in stimulated cycles for in vitro fertilization/embryotransfer treatment (IVF/ET) with a gonadotropin releasing hormone antagonist/recombinant follicle stimulating hormone (GnRH antagonist/recFSH) protocol (2004) (1)
Estimation of spontaneous pregnancies in patients after unsuccessful ICSI treatment. (2002) (1)
Long-acting FSH analogue: Corifollitropin-α to sustain multifollicular growth during controlled ovarian stimulation (2009) (1)
Session 31: Ovarian Stimulation 1 (2010) (1)
Should PGD be performed in RPL?: – Against (2007) (1)
Psychology and counselling A survey on the intentions and attitudes towards oocyte cryopreservation for non-medical reasons among women of reproductive age (2011) (1)
Prognostic factors for delivery in patients undergoing repeated preimplantation genetic aneuploidy screening. (2010) (1)
Diagnosis and treatment of proximal and distal tubal obstruction (1995) (1)
Immature oocyte in-vitro maturation: clinical (2005) (1)
Session 07: Psychology & Counselling 1 (2010) (1)
IVF/ICSI patients predicted to be high responders by their AMH level may benefit from HP-hMG treatment (2012) (1)
Provision of donor information to the offspring: the opinion of candidate semen donors, students and fathers (1999) (1)
Ejaculatory sperm production in non-obstructive azoospermic patients with a history of negative testicular biopsy after the administration of an aromatase inhibitor: report of two cases. (2014) (1)
Is spontaneous natural cycle the ideal method for planning vitrified/thawed blastocyst transfer in normovulatory patients? (2012) (1)
The influence of age on reproductive outcome in preimplantation genetic diagnosis (PGD) (2008) (1)
Blastocyst formation rate after ICSI with extreme oligozoospermic samples (2003) (1)
Endoscopic and Microsurgical Techniques in Reproductive Failure (1997) (0)
Administration of a GnRH antagonist during 3 days at initiation of the cycle: impact on the stimulation in IVF/ICSI (2010) (0)
[Curreny results of GIFT and ZIFT]. (1990) (0)
GnRH-agonist vs. GnRH-antagonist in elective single blastocyst transfer IVF cycles (2007) (0)
Session 56: Endometrial Function Determines Implantation Success (2010) (0)
Signal Transduction of Hcg Induces Decidualization and Uterine Receptivity (2017) (0)
Azoospermia and intracytoplasmic sperm injection. (1995) (0)
Infertility Cross-border reproductive care in Belgium (2009) (0)
Chromosomal abnormalities in female patients with regular cycles attending a fertility clinic. (2001) (0)
Ovulation Rate With a Highly Purified Menotropin and a Recombinant FSH in Women Unresponsive to Clomiphene Citrate (2005) (0)
Corifollitropin alfa demonstrates similar pregnancy rates as compared to daily recombinant FSH treatment in a controlled ovarian stimulation regimen for IVF/ICSI (2008) (0)
Reply: Modified natural cycle IVF for poor responders (2005) (0)
o-113 the effect of luteal support on pregnancy rates in normo- ovulatory patients stimulated with clomiphene citrate for iui:a prospective randomized study (2010) (0)
QUALITY AND SAFETY OF ART THERAPIES (2012) (0)
Report on a Consecutive Series of 581 Children Born After Blastomere Biopsy for Preimplantation Genetic Diagnosis (2010) (0)
Estimation of spontaneous pregnancies in patients after unsuccessful ICSI treatment (2002) (0)
Morphological and genomic endometrial development with long-acting degarelix starting in the mid-luteal or early follicular phase compared to daily ganirelix starting in the mid-follicular phase (2008) (0)
The moral value of reproductive agreements in the context of medically assisted reproduction (2000) (0)
Stem Cells and Preimplantation Embryos HLA-G Expression in Human Embryonic (0)
Prediction of Ongoing Pregnancy in an IVF Cycle Based on Clinical, Sonographic and Endocrine Parameters at Baseline (2005) (0)
Compaction and blastulation after thawing and overnight culture of frozen day 3 embryos are reliable predictors of clinical pregnancy (2008) (0)
Psychological follow-up study of 5 year old Belgian ICSI Children (2002) (0)
The current status of preimplantation genetic screening (2010) (0)
Infertility and Assisted Reproduction: The Future of Assisted Reproduction (2008) (0)
MIFT versus IVF/ICSI-ET: A Randomized, Prospective Study (2000) (0)
Can further in vitro culture of surviving frozen-thawed multicellular human embryos select viable embryos for transfer ? (1997) (0)
Pregnancy After Assisted Reproductive Technology: Pregnancy after intracytoplasmic spermatozoon injection (2012) (0)
P-021 Testicular sperm distribution in azoospermia (1997) (0)
[Echography in the infertility clinic]. (1988) (0)
SELECTED ORAL COMMUNICATION SESSION, SESSION 34: EARLY PREGNANCY LOSS PROGNOSIS AND TREATMENT, Tuesday 5 July 2011 10:00 – 11:30 (2011) (0)
FAST-TRACK Diagnostic efﬁciency, embryonic development and clinical outcome after the biopsy of one or two blastomeres for preimplantation genetic diagnosis (2008) (0)
HLA-G expression in undifferentiated human embryonic stem cells (2011) (0)
SELECTED ORAL COMMUNICATION SESSION, SESSION 68: EMBRYOLOGY - THE OOCYTE Wednesday 6 July 2011 14:00 - 15:45 (2011) (0)
How to Improve your ART Success Rates: Agonists or antagonists for ovarian stimulation? (2011) (0)
Is endometrial thickness, assessed on the day of HCG administration, predictive of ongoing pregnancy in patients undergoing intrauterine insemination after ovarian stimulation with clomiphene citrate? (2002) (0)
SELECTED ORAL COMMUNICATION SESSION, SESSION 33: AGONISTS AND ANTAGONISTS, Tuesday 5 July 2011 10:00 – 11:30 (2011) (0)
Endometrium receptivity in in-vitro maturation (IVM) treatment (2010) (0)
Different profile and early pregnancy outcome in early and late presentation pattern of ovarian hyperstimulation syndrome (2004) (0)
Ovulation triggering with urinary vs. recombinant HCG in CnRH-antagonist IVF cycles with single blastocyst transfer. a randomised controlled trial (2007) (0)
Attitude towards the acceptability of controversial groups as recipients and donors of sperm (2000) (0)
Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle- stimulating hormone (FSH) and GnRH-a and urinary FSH (1996) (0)
O-087. Egg-sharing does not jeopardize the pregnancy rate in oocyte donors (1999) (0)
Oocytes collected from small follicles after a dual trigger with gonadotropin-releasing hormone agonist (Gn-RHa) and human chorionic gonadotropin (hCG) for final oocyte maturation, in poor responder patient do not impact negatively ICSI cycles outcomes (2023) (0)
ESHRETask Force onEthics andLaw 22 : Preimplantation Genetic Diagnosis † (2014) (0)
Is addressing the needs of its membership an easy task for the American Society for Reproductive Medicine? (2004) (0)
Evaluation of aseptic blastocyst vitrification in preimplantation genetic diagnosis patients (2010) (0)
Clinical Aspects of Female Infertility (1989) (0)
Elective single blastocyst transfer and the cryo-augmentation effect of aseptic vitrification: a comparison of two strategies (2010) (0)
ART children are doing well: latest data from the Brussels follow-up studies (2001) (0)
O-155. Expectancy of pregnancy and pregnancy outcome in couples undergoing homologous IUI in clomiphene citrate-stimulated cycles (1997) (0)
Misoprostol prior to hysteroscopy in premenopausal and postmenopausal patients. A meta-analysis of randomized trials (2011) (0)
Review Elective single embryo tr ansfer (2008) (0)
Session 69: Factors Influencing Fertility and Infertility Treatment (2010) (0)
P-184. Percoll gradient centrifugation can be omitted in sperm preparation for ICSI (1997) (0)
Reproductive epidemiology Blood pressure in ICSI-conceived adolescents (2012) (0)
[Salpingitis and its consequences for fertility]. (1993) (0)
n 74 n the future of assisted reproduction (2008) (0)
Discomfort and complications related to oocyte retrieval: a prospective cohort study (2013) (0)
COX-2 as a possible predictive marker for clinical pregnancy in IVF (2008) (0)
Der Schadensfall / Failure Examination (1973) (0)
SELECTED ORAL COMMUNICATION SESSION, SESSION 49: EMBRYOLOGY – THE FERTILIZATION PROCESS, Tuesday 5 July 2011 17:00 – 18:00 (2011) (0)
Microsurgery for male infertility. (1981) (0)
Spontaneous live births in couples discontinuing ICSI treatment: a follow-up of five years. (2001) (0)
Is donor sperm associated with a higher incidence of pre-eclampsia as compared to insemination with partner's sperm? (2008) (0)
POSTER VIEWING SESSION - PSYCHOLOGY AND COUNSELLING (2011) (0)
Comparison between chorionic gonadotropin hormone profiles in pregnancies obtained after gamete intra-follopian transfer (GIFT), in vitro fertilization (IVF) or transfer of frozen embryos (1987) (0)
Chapter-65 Long-acting recombinant FSH (FSH-CTP, Corifollitropin alfa) (2016) (0)
Paramedical Session 1 Results of an artificial insemination programme with cryopreserved donor spermatozoa (1996) (0)
The first DK Tank International Conference on obstetrics, gynecology and fertility (2011) (0)
The Use of GnRH Analogues for Synchronization of Oocyte Donation (1990) (0)
Medical Views on Assisted Procreation (1992) (0)
PGS - hype or hope? (2006) (0)
Can a successful testicular sperm recovery be predicted in 47,XXY klinefelter patients? (2003) (0)
Does exogenous LH activity influence the outcome in IVF and not in ICSI cycles (2003) (0)
Reply: Letter to the Editor of Human Reproduction Update (2010) (0)
Arguments against preimplantation aneuploidy screening (2009) (0)
Safety of FF-MAS for in vitro maturation of cumulus-enclosed oocytes: The first prospective randomized control study in 301 women (2004) (0)
R-215. Serum and follicular fluid Cetrorelix concentrations in ovarian stimulation cycles (1997) (0)
Session 35 : Paramedical selected oral presentations-Laboratory 08 July 2008 11 : 45 – 12 : 45 O-132 Oral Influence of semen storage conditions on sperm DNA fragmentation analysis (2008) (0)
P-119 Testicular sperm extraction (TESE) and intracytoplasmic sperm injection (ICSI) for non-obstructive azoospermia (1997) (0)
Reply: Agonist trigger in the context of OHSS prevention: primum non nocere (2006) (0)
Live birth rate after single blastocyst transfer in a GnRH antagonist cycle using highly purified menotropin or recombinant fsh for controlled ovarian stimulation (2011) (0)
Accuracy of simplex PCR on two blastomeres in PGD for monogenic diseases: a retrospective analysis (2003) (0)
Chapter-23 Fine-tuning the role of GnRH antagonists in ART programs (2016) (0)
R-103. The quest for the ideal catheter (1999) (0)
PostersEmbryology (Embryo Selection) (2010) (0)
Corifollitropin stimulation in combination with GnRH-antagonists after estradiol valerate pre-treatment. A pilot study on patientfriendly IVF (2015) (0)
Single embryo transfer in preimplantation genetic diagnosis cycles for women <36 years does not reduce delivery rate. Authors' reply (2007) (0)
Measurements of serum 17 beta estradiol and progesterone by direct radioimmunoassays in orally substituted patients receiving oral steroid substitution therapy (1986) (0)
Initiation of Gonadotrophin Releasing Hormone (GnRH) antagonist on day one as compared to day six of stimulation: effect on hormonal levels and follicular development in IVF/ICSI cycles (2003) (0)
R-110. OHSS: an unclear clinical condition (1997) (0)
RECOVERY OF UREAPLASMA UREALYTICUM IN SEMEN AND RELATIONSHIP TO SEMEN EVALUATION (1986) (0)
The Association of Ovarian Hyperstimulation and Zygote Intrafallopian Transfer (1990) (0)
Repetitivity and therapy of luteinized unruptured follicle syndrome (1984) (0)
The endocrine profile of in-vitro maturation treatment cycles (2010) (0)
Synchronisation of the follicle cohort with the GnRH antagonist degarelix: a randomised, assessor-blind, placebo-controlled trial (2008) (0)
Multiple pregnancy after assisted reproduction (2005) (0)
PostersSafety & Quality (I.E. Guidelines, Multiple Pregnancy, Outcome, Follow-Up etc.) (2010) (0)
The relationship between trinucleotide repeat length and reproductive outcome in myotonic dystrophy type 1 (DM1) (2008) (0)
Does earlier administration of human chorionic gonadotropin (hCG) improve the probability of pregnancy in cycles stimulated with rec-FSH and GnRH antagonists? A prospective randomized trial (2011) (0)
P-296: Embryo deposition in lower uterine cavity does not affect implantation and pregnancy rates: A randomized controlled trial (2006) (0)
Intracytoplasmic sperm injection – an update (2001) (0)
The value of basal serum LH measurement in predicting genetic (2005) (0)
P-161 General anesthesia using propofol versus locoregional anesthesia for transvaginal oocyte retrieval: Reproductive outcome (1997) (0)
SELECTED ORAL COMMUNICATION SESSION, SESSION 72: FEMALE FERTILITY AND ART Wednesday 6 July 2011 14:00 - 15:45 (2011) (0)
O-266 Oral Outcome of blastocyst transfers after thawing and culture of cryopreserved pronuclear zygotes The incidence of monozygotic twinning after pre-implantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS) is not increased (2009) (0)
RESULTATS ET APPLICATIONS POSSIBLES DE LA MICROBIOPSIE DE L'OEUF: DETERMINATION DU SEX ET ANOMALIES GENIQUES (1992) (0)
SESSION 20: FEMALE INFERTILITY 2 (2012) (0)
Reproductive epidemiology Pubertal development in ICSI children (2012) (0)
SESSION 55: DEBATE: SHOULD WE TREAT THE MAN OR JUST USE THE SPERM? (2012) (0)
Intracytoplasmic sperm injection. Review (1994) (0)
O-119 The effect of the intravenous anesthetic propofol on fertilization and early embryo development in human in vitro fertilization (IVF) program (1997) (0)
Synchronization in Ovum Donation (1990) (0)
Posters * Early Pregnancy (2010) (0)
versus cycle day 5 with GnRH antagonist in IVF treatment: a randomized controlled trial (2011) (0)
Effect on endocrine parameters of the addition of letrozole to the recombinant FSH-GnRH antagonist ovarian stimulation scheme used for IVF (2004) (0)
Public attitude towards social freezing and characterization of potential oocyte freezers. (2010) (0)
Meta-analysis on luteal phase support. (2003) (0)
Comment 1 on: Design and analysis of a randomized controlled trial studying preimplantation genetic screening. Authors' reply (2005) (0)
Reply: Comparing highly purified hMG and rFSH in patients undergoing IVF (2007) (0)
Clinical results with intracytoplasmic sperm injection. (1997) (0)
The qTiology Of Certain Lesions Of The Skin (1924) (0)
Letters-to-the-editorReply of the Authors (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Paul Devroey?

Paul Devroey is affiliated with the following schools:

Vrije Universiteit Brussel